Equation | Mean estimated GFR* (mL/min/1.73 m2) | |||||
---|---|---|---|---|---|---|
All patients | Body mass index (kg/m2) | P for trend | ||||
<20 | 20–25 | 25–30 | >30 | |||
Creatinine 2009—age, sex, and race | 88 ± 17 | 87 ± 18 | 88 ± 17 | 88 ± 17 | 89 ± 19 | 0.2 |
Cystatin C 2012—age and sex | 83 ± 21 | 83 ± 23 | 85 ± 21 | 83 ± 20 | 78 ± 21 | <0.001 |
Creatinine-cystatin C 2012 (age, sex, and race) | 86 ± 19 | 85 ± 20 | 87 ± 19 | 86 ± 18 | 84 ± 20 | 0.02 |
Average of creatinine 2009 and cystatin C 2012 | 85 ± 17 | 85 ± 19 | 86 ± 17 | 85 ± 17 | 84 ± 23 | 0.03 |
Spline Log cystatin C | 88 ± 22 | 89 ± 2 | 90 ± 22 | 88 ± 22 | 83 ± 23 | <0.001 |
Spline Log cystatin C—age, sex, and race | 82 ± 21 | 82 ± 23 | 84 ± 20 | 83 ± 20 | 77 ± 21 | <0.001 |
Spline Log cystatin C—age, sex, and diabetes | 85 ± 20 | 84 ± 22 | 86 ± 20 | 85 ± 20 | 80 ± 21 | <0.001 |
Spline Log cystatin C—age, sex, and weight | 81 ± 21 | 78 ± 22 | 82 ± 20 | 82 ± 20 | 79 ± 22 | 0.8 |
*Estimated GFR reported as mean ± SD.